Results 231 to 240 of about 1,107,303 (283)
Some of the next articles are maybe not open access.

Amyloid Beta: The Alternate Hypothesis

Current Alzheimer Research, 2006
Alzheimer disease (AD) is a devastating condition and patients, caregivers, clinicians, and scientists are eager to decipher the underlying disease mechanism and, thereafter, target this therapeutically. Most investigators studying the underlying cause of AD have focused on amyloid-beta (Abeta) such that the Amyloid Cascade Hypothesis is the ...
Hyoung-gon, Lee   +4 more
openaire   +2 more sources

Amyloid beta.

The international journal of biochemistry & cell biology, 1999
Amyloid beta (A beta) is a 39-43 residue amyloidogenic peptide that is deposited into the extracellular amyloid plaques which characterize an Alzheimer's disease (AD) brain. A beta is derived from the amyloid precursor protein (APP) and undergoes a toxic conformational change (gain of toxic function).
R, Cappai, A R, White
openaire   +1 more source

Amyloid beta antagonizes insulin promoted secretion of the amyloid beta protein precursor

Journal of Alzheimer's Disease, 2002
Amyloid β (Aβ) peptides are direct competitive inhibitors of insulin binding and action [25]. We demonstrate that Aβ peptides can inhibit the effect of insulin on the metabolic processing of the amyloid β protein precursor (AβPP). As evidence emerges concerning the role of insulin and insulin like growth factors (IGFs) in learning and memory, recent ...
Xie, Ling   +4 more
openaire   +2 more sources

Amyloid and the Cross-Beta Architecture

Journal of Visualized Experiments
Amyloid fibrils are made up of a misfolded, self-assembled protein organised into a well-defined, repetitive structure. They are well known for their important role in protein misfolding diseases, including Alzheimer's disease and type 2 diabetes, in which the insoluble amyloid fibrils are deposited in the tissues.
Kyle, Morris   +4 more
openaire   +2 more sources

Beta-amyloid immunisation in Alzheimer’s disease

Neurological Sciences, 2005
Beta-amyloid immunisation in Alzheimer's ...
openaire   +2 more sources

Amyloid Beta in Aging and Alzheimer’s Disease

International Journal of Molecular Sciences, 2022
Jonathan Kopel   +2 more
exaly  

Human anti-beta-amyloid antibodies block beta-amyloid fibril formation and prevent beta-amyloid-induced neurotoxicity.

Brain : a journal of neurology, 2003
The accumulation of beta-amyloid (A beta) in neuritic plaques is thought to be causative for the progression of Alzheimer's disease (AD). Recently, both active immunization and passive administration of A beta antibodies dramatically attenuated amyloid plaque deposition, neuritic dystrophy, astrogliosis and behaviour deficits in transgenic animals.
Yansheng, Du   +9 more
openaire   +1 more source

Higher CSF sTREM2 and microglia activation are associated with slower rates of beta‐amyloid accumulation

EMBO Molecular Medicine, 2020
Michael Ewers   +2 more
exaly  

Amyloid-Beta

2010
Jean-Michel Scherrmann   +199 more
openaire   +1 more source

Amyloid Beta Neurotoxicity

2017
1.
Ho, WL   +6 more
openaire   +1 more source

Home - About - Disclaimer - Privacy